RESUMO
The aim of this work was to evaluate the effect of the Rolipram during the maturation of bovine oocytes and gene expression of embryos produced in vitro. Bovine ovaries were collected in slaughterhouse. The COCs were selected and divided into 5 groups: Control 0 time; Control: IVM for 24 hours; Rolipram treatments with IVM blocking for 24 hours in maturation medium containing (100, 150 and 200µM). After 24 hours all groups were reseated in IVM for another 24 hours. Subsequently COCs were subjected to the same IVM system and fertilized, being checked for cleavage post fertilization and for blastocyst. In addition, performed expression of the following genes: Mater, BMP15 and Bax. No difference was found in gene expression. Of oocytes evaluated shortly after follicular aspiration, 79.00% were in GV, GVBD, MI, while 13.40%, were in MII and 7.60%, D/NI. Significant difference was observed in different concentrations (T100, T200 and T150µM) in oocytes that have reached the MII phase compared to control treatments (P= 0.003). Differences were observed in cleavage rate (P< 0.05) between T150 and T200 when compared to the C/24 Group. A high difference was observed on blastocyst rate (P< 0.001) among treatments compared to the control group.(AU)
O objetivo deste trabalho foi avaliar o efeito do rolipram durante a maturação de oócitos bovinos, expressão gênica e embriões produzidos in vitro. Os ovários bovinos foram coletados no matadouro. Os COCs foram selecionados e divididos em cinco grupos: controle 0 tempo; controle: MIV por 24 horas; tratamentos rolipram com bloqueio MIV por 24 horas em meio de maturação contendo 100, 150 e 200µM. Após 24 horas, todos os grupos foram recolocados em MIV por mais 24 horas. Subsequentemente COCs foram submetidos ao mesmo sistema MIV e fertilizados, sendo avaliada a taxa de clivagem e de blastocisto, além da expressão dos seguintes genes: Mater, BMP15 e Bax. Nenhuma diferença foi observada na expressão gênica. Dos oócitos avaliados logo após a aspiração folicular, 79,0% estavam em GV, GVBD, MI, enquanto 13,40% estavam em MII, e 7,60% em D/NI. A diferença significativa foi observada em diferentes concentrações (T100, T200 e T150µM) em oócitos que atingiram a fase MII em comparação aos tratamentos de controle (P=0,3). Diferenças foram observadas nas taxas de clivagem (P<0,5) entre T150 e T200 quando comparadas com as taxas do grupo C/24. Uma grande diferença foi observada na taxa de blastocisto (P<0,1) entre os tratamentos em relação ao grupo controle.(AU)
Assuntos
Animais , Feminino , Bovinos , Oócitos/crescimento & desenvolvimento , Expressão Gênica/efeitos dos fármacos , Rolipram/farmacologia , Desenvolvimento Embrionário/efeitos dos fármacos , Técnicas In Vitro/métodos , Técnicas In Vitro/veterináriaRESUMO
RESUMEN El consumo de ácido fólico se ha relacionado con la disminución en la incidencia de malformaciones congénitas y deficiencias obstétricas, pero existen criterios de que no siempre su uso tiene los efectos favorables esperados para la madre y su descendencia. Con el objetivo de estructurar los presupuestos teóricos que sustentan el beneficio y el riesgo del consumo de ácido fólico para el embarazo, se realizó una búsqueda sobre el tema consultándose 37 referencias bibliográficas actualizadas. El ácido fólico ostenta dos grandes funciones en el organismo: la síntesis y reparación de los ácidos nucleicos, así como la síntesis del aminoácido metionina a partir de la homocisteina, esta última, al acumularse en el organismo se asocia a defectos congénitos y enfermedades crónicas del adulto. A partir de estos aspectos se corrobora que su consumo antes y durante el embarazo es beneficioso pues previene defectos del tubo neural, algunas cardiopatías congénitas, hendiduras bucofaciales, síndrome de Down, desórdenes del espectro autista, infecciones obstétricas, preeclampsia, hemorragia uterina, desprendimiento abrupto de la placenta, retardo del crecimiento intrauterino y prematuridad. El consumo excesivo de más de 5 mg/día se ha asociado a anemia por deficiencia de vitamina B12, déficit de zinc, crecimiento intrauterino retardado y prematuridad; en modelos animales acelera la transformación maligna de tumores existentes. Se concluye que el ácido fólico contribuye a preservar una embriogénesis y placentación normal y no se han demostrado efectos adversos por su uso, pero debe ser consumido en la dosis adecuada y por prescripción médica.
ABSTRACT Acid folic intake has been related to the decrease in the incidence of congenital malformations and obstetric deficiencies but there are criteria about folic acid not always achieving the expected favorable results for mothers and their descendants. A search on the theme was carried out with the objective of structuring the theoretical assumptions upholding the benefit and risk of folic acid intake for pregnancy. 37 updated bibliographic references were consulted. The folic acid has two main functions in the organism: nucleic acids´ synthesis and repair, and also the synthesis of the methionine amino acid from homocystein; when the last one accumulates in the organism, it is associated to congenital defects and adults´ chronic diseases. Beginning from these aspects, it is stated that the intake before and after pregnancy is beneficial because it prevents defects of the neural tube, some congenital deficiencies, oral facial clefts, Down syndrome, autism spectrum disorders, obstetric infections, preeclampsia, uterine hemorrhage, sudden placental abruption, intrauterine grow retardation and prematurity. The excessive intake of more than 5 mg/d has been associate to anemia due vitamin B12 deficiency, zinc deficiency, intrauterine retarded grow and prematurity; in animal models it speeds up the malignant transformation of existent tumors. The authors arrived to the conclusion that folic acid contributes to preserving a normal embryogenesis and placentation, and that no adverse effects have been demonstrated, nevertheless it should be taken in adequate doses and for medical prescription.
Assuntos
Humanos , Feminino , Gravidez/efeitos dos fármacos , Ácido Fólico/administração & dosagem , Ácido Fólico/efeitos adversos , Ácido Fólico/genética , Placentação/efeitos dos fármacos , Desenvolvimento Embrionário/efeitos dos fármacos , Ácido Fólico/uso terapêutico , Ácido Fólico/farmacologiaRESUMO
ABSTRACT The development of DBA/2J mouse strain embryos is nearly 12 h - or 6 somite pairs - delayed as compared to the outbred NMRI mouse embryos of the same age on gestation days (GD) 8-12. To evaluate inter-strain differences in susceptibility to teratogens, dams were treated with methylnitrosourea (MNU, 5 mg/kg body weight i.p.) on defined gestation days (NMRI: GD 9, 91/2 or 10; DBA/2J: GD 10 or 101/2). Skeletal anomalies produced by MNU on both mouse strains varied with the GD of treatment. The pattern of anomalies produced by MNU on a given GD markedly differed between the two mouse strains, yet they were similar -with a few exceptions- when exposures at equivalent embryonic stages are compared. Findings from this study indicated that strain-dependent differences in the developmental stage of mouse embryos of the same gestational age occur, a possibility that has been often neglected when inter-strain differences in susceptibility to developmental toxicants are interpreted.
Assuntos
Animais , Feminino , Gravidez , Ratos , Esqueleto/anormalidades , Teratogênicos/toxicidade , Somitos/anormalidades , Desenvolvimento Embrionário/efeitos dos fármacos , Embrião de Mamíferos/anormalidades , Metilnitrosoureia/toxicidade , Esqueleto/efeitos dos fármacos , Esqueleto/embriologia , Somitos/efeitos dos fármacos , Somitos/embriologia , Embrião de Mamíferos/efeitos dos fármacos , Camundongos Endogâmicos DBARESUMO
The objective of this study was to evaluate the effects of several different commercial disinfectants on the embryogenic development of Ascaris suum eggs. A 1-ml aliquot of each disinfectant was mixed with approximately 40,000 decorticated or intact A. suum eggs in sterile tubes. After each treatment time (at 0.5, 1, 5, 10, 30, and 60 min), disinfectants were washed away, and egg suspensions were incubated at 25℃ in distilled water for development of larvae inside. At 3 weeks of incubation after exposure, ethanol, methanol, and chlorohexidin treatments did not affect the larval development of A. suum eggs, regardless of their concentration and treatment time. Among disinfectants tested in this study, 3% cresol, 0.2% sodium hypochlorite and 0.02% sodium hypochlorite delayed but not inactivated the embryonation of decorticated eggs at 3 weeks of incubation, because at 6 weeks of incubation, undeveloped eggs completed embryonation regardless of exposure time, except for 10% povidone iodine. When the albumin layer of A. suum eggs remained intact, however, even the 10% povidone iodine solution took at least 5 min to reasonably inactivate most eggs, but never completely kill them with even 60 min of exposure. This study demonstrated that the treatment of A. suum eggs with many commercially available disinfectants does not affect the embryonation. Although some disinfectants may delay or stop the embryonation of A. suum eggs, they can hardly kill them completely.
Assuntos
Animais , Ascaris suum/efeitos dos fármacos , Desinfetantes/toxicidade , Embrião não Mamífero/efeitos dos fármacos , Desenvolvimento Embrionário/efeitos dos fármacos , Fatores de TempoRESUMO
Maytenus macrocarpa (MM) (Ruiz & Pav.) Briq. es un árbol utilizado por poblaciones amazónicas de forma medicinal, para el control de la fertilidad. El objetivo de este trabajo fue evaluar el efecto abortivo potencial de diferentes dosis del extracto acuoso de M. macrocarpa "chuchuwasi" (25, 50 y 100 mg/kg) sobre embriones preimplantacionales de ratón de la cepa albina Swiss Rockfeller. El extracto fue administrado a los ratones vía intraperitoneal entre el primer y cuarto día de gestación. Se evaluó la calidad y desarrollo de los embriones. Se realizó el test de Micronucleo (MN) a fin de conocer si el extracto de MM era genotoxico. Ninguno de los tratamientos mostro significancia en el número de embriones degradados o inviables y en la tasa de MN. Los resultados sugieren que el extracto acuoso de M. macrocarpa no tiene un efecto sobre el desarrollo normal de los embriones.
Assuntos
Animais , Camundongos , Extratos Vegetais , Desenvolvimento Embrionário/efeitos dos fármacos , Mutagênicos , Modelos AnimaisRESUMO
This study was conducted to investigate the effects of rapamycin treatment during in vitro maturation (IVM) on oocyte maturation and embryonic development after parthenogenetic activation (PA) and somatic cell nuclear transfer (SCNT) in pigs. Morphologically good (MGCOCs) and poor oocytes (MPCOCs) were untreated or treated with 1 nM rapamycin during 0-22 h, 22-42 h, or 0-42 h of IVM. Rapamycin had no significant effects on nuclear maturation and blastocyst formation after PA of MGCOCs. Blastocyst formation after PA was significantly increased by rapamycin treatment during 22-42 h and 0-42 h (46.6% and 46.5%, respectively) relative to the control (33.3%) and 0-22 h groups (38.6%) in MPCOCs. In SCNT, blastocyst formation tended to increase in MPCOCs treated with rapamycin during 0-42 h of IVM relative to untreated oocytes (20.3% vs. 14.3%, 0.05 < p < 0.1), while no improvement was observed in MGCOCs. Gene expression analysis revealed that transcript abundance of Beclin 1 and microtubule-associated protein 1 light chain 3 mRNAs was significantly increased in MPCOCs by rapamycin relative to the control. Our results demonstrated that autophagy induction by rapamycin during IVM improved developmental competence of oocytes derived from MPCOCs.
Assuntos
Animais , Feminino , Desenvolvimento Embrionário/efeitos dos fármacos , Técnicas de Maturação in Vitro de Oócitos/veterinária , Técnicas de Transferência Nuclear/veterinária , Oócitos/crescimento & desenvolvimento , Partenogênese , Sirolimo/farmacologia , Sus scrofa/crescimento & desenvolvimentoRESUMO
The advent of in vitro fertilization (IVF) in animals and humans implies an extraordinary change in the environment where the beginning of a new organism takes place. In mammals fertilization occurs in the maternal oviduct, where there are unique conditions for guaranteeing the encounter of the gametes and the first stages of development of the embryo and thus its future. During this period a major epigenetic reprogramming takes place that is crucial for the normal fate of the embryo. This epigenetic reprogramming is very vulnerable to changes in environmental conditions such as the ones implied in IVF, including in vitro culture, nutrition, light, temperature, oxygen tension, embryo-maternal signaling, and the general absence of protection against foreign elements that could affect the stability of this process. The objective of this review is to update the impact of the various conditions inherent in the use of IVF on the epigenetic profile and outcomes of mammalian embryos, including superovulation, IVF technique, embryo culture and manipulation and absence of embryo-maternal signaling. It also covers the possible transgenerational inheritance of the epigenetic alterations associated with assisted reproductive technologies (ART), including its phenotypic consequences as is in the case of the large offspring syndrome (LOS). Finally, the important scientific and bioethical implications of the results found in animals are discussed in terms of the ART in humans.
Assuntos
Humanos , Animais , Fertilização in vitro/ética , Biologia do Desenvolvimento/ética , Epigenômica/ética , Mamíferos/crescimento & desenvolvimento , Superovulação/ética , Risco , Espécies Reativas de Oxigênio/metabolismo , Diagnóstico Pré-Implantação , Temas Bioéticos , Técnicas de Cultura Embrionária/métodos , Desenvolvimento Embrionário/efeitos dos fármacos , Genes Controladores do Desenvolvimento/fisiologiaRESUMO
Meclizine and caffeine combination is used for the treatment of morning sickness. Both compounds are teratogenic and caffeine is known to possess anti-fertility activity also. The present study was undertaken to evaluate the reproductive toxic effect of meclizine and caffeine combination. Three doses were taken for the study; low dose (LD; meclizine 3.7 mg/kg and caffeine 3 mg/kg) was selected from commercially available formulation, middle dose (MD; meclizine 37 mg/kg and caffeine 30 mg/kg) and high dose (HD; meclizine 370 mg/kg and caffeine 300 mg/kg). The mixture was administered 1-7 days and 8-14 days for fertility and embryotoxic studies respectively. Laparotomy was done on 10th day of gestation period. Number of implants and corpora lutea were counted, pre and post-implantation losses were determined. In embryo toxicity study fetuses were evaluated for external, skeletal and visceral examination. High dose was removed from both fertility and embryotoxicity studies due to its severe toxicity to the dam. Significant anti-fertility activity was observed at middle dose. Embryotoxicity study showed significant reduction in fetal body weight, body length and body mass index, dam body weight gain on gestation day 14. Absolute kidney weight in MD and absolute and relative spleen weight in both LD and MD were significantly reduced. There was no increase in external or internal congenital anomalies at both LD and MD. The, results suggest that prescription of meclizine and caffeine for morning sickness in early pregnancy should be reviewed carefully.
Assuntos
Anormalidades Induzidas por Medicamentos/etiologia , Administração Oral , Animais , Peso Corporal/efeitos dos fármacos , Cafeína/administração & dosagem , Cafeína/toxicidade , Relação Dose-Resposta a Droga , Combinação de Medicamentos , Ingestão de Alimentos/efeitos dos fármacos , Desenvolvimento Embrionário/efeitos dos fármacos , Feminino , Fertilidade/efeitos dos fármacos , Peso Fetal/efeitos dos fármacos , Idade Gestacional , Antagonistas dos Receptores Histamínicos H1/administração & dosagem , Antagonistas dos Receptores Histamínicos H1/toxicidade , Rim/efeitos dos fármacos , Rim/patologia , Fígado/efeitos dos fármacos , Fígado/patologia , Masculino , Meclizina/efeitos dos fármacos , Meclizina/toxicidade , Tamanho do Órgão/efeitos dos fármacos , Antagonistas de Receptores Purinérgicos P1/administração & dosagem , Antagonistas de Receptores Purinérgicos P1/toxicidade , Ratos Wistar , Baço/efeitos dos fármacos , Baço/patologia , Aumento de Peso/efeitos dos fármacosRESUMO
The objective of this work was to evaluate the effect of using L-arginine during in vitro fertilization (IVF) on in vitro embryonic development using Bos taurus and Bos indicus semen. Effect of different concentrations (0, 1, 10 and 50 mM) of L-arginine, added to the IVF medium, was evaluated on the fertilization rate at 18 h post-fertilization (hpf), NO3-/NO2- production during IVF by the Griess colorimetric method (30 hpf), cleavage and blastocyst rates (on Day 2 and Day 7 of culture, respectively) and total blastocyst cell number (Day 7 of culture). The results reveal that the addition of 50 mM L-arginine to IVF medium, with either Bos taurus or Bos indicus spermatozoa, decreased the cleavage rate and blastocyst rate compared to the control group. Other concentrations did not affect embryo production. However, 1 mM L-arginine with Bos indicus semen increased the proportion of hatched blastocysts. These results indicate that high L-arginine concentrations may exhibit toxic effects on bovine gametes during in vitro fertilization.
Assuntos
Animais , Arginina , Blastocisto/citologia , Blastocisto/efeitos dos fármacos , Blastocisto/metabolismo , Bovinos , Relação Dose-Resposta a Droga , Embrião de Mamíferos/citologia , Embrião de Mamíferos/efeitos dos fármacos , Embrião de Mamíferos/metabolismo , Desenvolvimento Embrionário/efeitos dos fármacos , Feminino , Fertilização/efeitos dos fármacos , Fertilização in vitro/efeitos dos fármacos , Masculino , Microscopia de Fluorescência , Nitratos/metabolismo , Nitritos/metabolismo , Espermatozoides/efeitos dos fármacosRESUMO
El déficit y exceso de vitamina A provoca malformaciones congénitas que afectan distintos órganos y sistemas. El objetivo de este estudio fue determinar el efecto que causa la administración de ácido retinoico a distintas dosis sobre la morfogénesis ósea del esqueleto axial en embriones de ratón Mus musculus. Mediante aleatorización simple se distribuyeron hembras recién preñadas en 4 categorías: A, B, C y D. El día 8 post fecundación (p.f), se administró 40 mg/kg de peso de ácido retinoico al grupo A, 20 mg/kg de peso de esta solución al grupo B, 1 ml/kg de peso de dimetil sulfóxido al grupo C, y el grupo D es grupo control. El día 17 de la gestación las hembras y sus fetos fueron anestesiadas y eutanasiadas con sobredosis de pentotal sódico intraperitoneal. Los fetos de cada camada fueron procesados mediante diafanización y tinción con azul de Alcian para destacar cartílago hialino y alizarina para observar tejido óseo. Los resultados se expresaron en porcentajes de malformaciones en los siguientes tres segmentos: 1) cráneo-columna cervical, 2) segmento torácico y abdominal y 3) cintura pélvica, considerándose un 100% cuando la totalidad de los elementos óseos se encontraban comprometidos. Se utilizó la prueba de Fisher para la comparación de frecuencias de malformaciones y se consideró estadísticamente significativo cuando p<0,05. En el grupo A se evidenciaron malformaciones mayores como ausencia de huesos frontales y parietales, exencefalia, defectos en el número de vértebras, y fusiones de costillas; y en el grupo B se observaron malformaciones menores como alteraciones numéricas y fusiones de costillas, existiendo diferencias significativas entre ambos grupos. En los grupos C y D no se consignaron malformaciones. El ácido retinoico administrado intraperitonealmente el dìa 8 p.f en dosis de 40 y 20 mg/kg de peso se comporta como un teratógeno en los embriones de ratón, existiendo además diferencias significativas entre las malformaciones generadas por ambas dosis de ácido retinoico. La primera concentración afecta los huesos de los tres segmentos estudiados (cráneo-cervical, toracoabdominal, y pélvico) y la segunda concentración sólo afecta a dos segmentos (cráneo-cervical y toracoabdominal). Ambos tratamientos afectan los segmentos en una gradiente céfalo caudal, independiente del origen embrionario de las estructuras. Esto se debería a que los cambios en las gradientes de ácido retinoico alteran el comportamiento de células de la cresta neural craneal y el orden de la expresión de genes Hox.
The deficit and excess of vitamin A causes birth defects affecting different organ systems. The objectives of this study are to determine the effect caused by the administration of different doses of retinoic acid on bone morphogenesis of the axial skeleton in embryonic mouse Mus musculus. By simple randomization newly pregnant females were distributed into 4 categories: A, B, C and D. On day 8 post fertilization, 40 mg/kg was administered by weight of retinoic acid to the group A, 20 mg/kg body weight of the group B solution 1 ml/kg body weight of dimethyl sulfoxide and group C. Group D is the control group. On day 17 of gestation the females and their fetuses were anesthetized and euthanized with an overdose of intraperitoneal sodium pentothal. Fetuses from each litter were processed using diaphanization and Alcian blue staining to hyaline cartilage and alizarin to observe bone tissue. The results are expressed as percentages of malformations in the following three segments: 1) cranio-cervical spine, 2) thoracic and abdominal segment and 3) pelvic segment, considering 100% when all the bony elements were compromised. Fisher's exact test for comparison of frequencies of malformations was used and considered statistically significant when p<0.05. In group A, major malformations and defects were evident in the indemnity of the cranial vault, exencephaly, defects in the number of vertebrae, and fusion of ribs. In group B minor malformations as numerical alterations and rib fusions were observed. Significant differences were found between both groups. In groups C and D no malformations were recorded. Retinoic acid administered intraperitoneally at doses of 40 and 20 mg/kg acts as a teratogen in mouse embryos. There are significant differences between the defects induced by concentrations of 40 mg/k and 20 mg/k of retinoic acid. Both concentrations affect the bones of the three segments studied (cranio cervical, thoraco-abdominal and pelvic) in a cephalo caudal gradient, independent of the embryonic origin of the structures. Changes in retinoic acid concentration alter the behavior of cranial neural crest and changing the order of the HOX gene expression in the axial skeleton.
Assuntos
Animais , Masculino , Feminino , Camundongos , Tretinoína/administração & dosagem , Anormalidades Múltiplas/induzido quimicamente , Desenvolvimento Ósseo/efeitos dos fármacos , Embrião de Mamíferos/efeitos dos fármacos , Teratogênicos , Tretinoína/farmacologia , Desenvolvimento Embrionário/efeitos dos fármacosRESUMO
Citrinin is the one of the well-known mycotoxins, which is possibly spread all over the world. The graded doses of citrinin (1, 3 and 5 ppm CIT in feed) in female Wistar rats 10 weeks prior to mating, during mating and during organogenesis resulted in resorptions and post implantation losses, decreased fetal body weights and crown-rump lengths in fetuses of all groups. Various developmental anomalies recorded in fetuses of treated rats included gross (wrist drop, curled tail, stretched forelimb, subcutaneous haematoma), skeletal (incomplete ossification of skull bones, incomplete fusion of vertebral bodies, complete and partial agenesis of sternaebrae, metacarpals, metatarsals and phalanges, fused ribs and swing out ribs) and visceral (internal and external hydrocephalus, cerebellar hypoplasia, microphthalmia, roundening of heart, contracted kidneys, dilated renal pelvis and cryptorchid testes). The results suggest that CIT has adverse effects on fetal development which may be due to the longer bioavailability of citrinin in the animals.
Assuntos
Anormalidades Induzidas por Medicamentos/classificação , Anormalidades Induzidas por Medicamentos/metabolismo , Anormalidades Induzidas por Medicamentos/patologia , Animais , Citrinina/administração & dosagem , Citrinina/efeitos adversos , Perda do Embrião/induzido quimicamente , Perda do Embrião/patologia , Desenvolvimento Embrionário/efeitos dos fármacos , Feminino , Desenvolvimento Fetal/efeitos dos fármacos , Masculino , Micotoxinas/toxicidade , Ratos , Ratos Wistar , Reprodução/efeitos dos fármacos , TeratologiaRESUMO
Enrichment of culture media with amino acids improves embryo development. However, little is known about the specific action of each amino acid during embryogenesis. The present study was undertaken to examine the effect of L-glutamine (Gln) and tryptophan (Trp) on mouse embryo hatching, expansion and viability in vitro. Blastocysts were collected from 6- to 8-week-old female BALB/c mice (N = 30) and cultured in M2 medium containing either 0.125, 0.25 or 0.5 mM Trp, 1 mM Gln, or M2 alone. Gln significantly increased (100 percent; P < 0.05) blastocyst hatching at 24 h compared to M2 alone or Trp; moreover, Trp inhibited blastocyst hatching when compared to M2 alone (P < 0.05) at 72 h. In contrast, the percentage of embryos reaching the state of expanded blastocyst at 48 h was significantly higher in medium with 1 mM Gln (66.6 percent; P < 0.05) or with 0.125 mM Trp (61.1 percent; P < 0.05). Unexpectedly, Trp increased the percentage of degenerated blastocysts after 48 h (67.7 percent; P < 0.05), while Gln preserved blastocyst viability. These results suggest that Gln may enhance blastocyst hatching, expansion and viability in vitro.
Assuntos
Animais , Feminino , Camundongos , Blastocisto/efeitos dos fármacos , Meios de Cultura/química , Desenvolvimento Embrionário/efeitos dos fármacos , Glutamina/farmacologia , Técnicas In Vitro , Triptofano/farmacologia , Blastocisto/metabolismo , Sobrevivência Celular , Células Cultivadas , Técnicas de Cultura Embrionária/métodos , Camundongos Endogâmicos BALB C , Fatores de TempoRESUMO
A ipriflavona possui efeito inibitório sobre o citocromo p450 e sobre a proliferação do DNA, interferindo na síntese de hormônios estereoidianos, e consequente interferência no transporte e desenvolvimento pré-implantacional e na implantação do blastocisto. Consumidos em altas doses pode acarretar abortamentos e malformações. Para verificar a embriotoxicidade da ipriflavona durante as fases de transporte tubário e implantação do blastocisto de ratas, ratas Wistar prenhes foram tratadas duas vezes ao dia com 1mL de suspensão aquosa de ipriflavona, nas doses de 0 (C), 300 (T1), 1500 (T2) e 3000 (T3) mg/kg/dose, durante os oito primeiros dias de prenhez com eutanásia no 14o dia. Indícios de toxicidade foram avaliados por análises hematimétricas, bioquímicas e comportamentais. Foram contados fetos vivos, mortos e reabsorvidos (inicial e tardiamente). Os animais não apresentaram sinais clínicos de toxicidade. Índice de implantação e perdas pré-embrionária sofreram interferência do uso da ipriflavona. Dados apontam para um efeito estrogênico da ipriflavona, observados na interferência da implantação do blastocisto de ratas Wistar.
Ipriflavone has inhibitory effect on the cytochrome p450 and the proliferation of DNA, interfering with hormone synthesis estereoidianos, and consequent interference with the transport and preimplantation development and implantation of the blastocyst. Consumed in high doses can cause miscarriages and malformations. To verify the embryotoxicity of ipriflavone during the phases of tubal transport and implantation of the blastocyst in rats, Wistar rats were treated twice daily with 1 mL of aqueous suspension of ipriflavone at doses of 0 (C), 300 (T1), 1500 (T2) and 3000 (T3) mg / kg / dose during the first eight days of pregnancy with euthanasia on day 14. Signs of toxicity were characterized by hematological, biochemical and behavioral. Live fetuses were counted, dead and resorbed (early and late). The animals showed no clinical signs of toxicity. Index pre-implantation embryo and losses suffered interference from the use of ipriflavone. Data point to an estrogenic effect of ipriflavone, due to interference in blastocyst implantation in Wistar rats.
Assuntos
Animais , Ratos , Implantação do Embrião , Flavonoides/toxicidade , Desenvolvimento Embrionário/efeitos dos fármacos , Isoflavonas/toxicidade , Ensaio Clínico , Ratos WistarRESUMO
Previous studies indicated that morphine consumption during pregnancy could inhibit embryos development. Present study further evaluated the effects of oral morphine consumption on the placenta lacunas development in ten day pregnant Wistar rats. Female Wistar rats [W: 170-200 gr] were used in the present study. Experimental group were received morphine [0.05 mg/ml of tap water] after one night coupling with male rats for mating. On the day 10th of pregnancy, the pregnant animals were killed with chloroform and the placentas and uterus were removed surgically and fixed in 10% formalin for twenty days. The fixed placentas were processed and stained by H and E method and evaluated for their development. Thickness of layers, surface area of lacuna, as well as the number of cells in both maternal and fetal parts of the placentas was assessed by light microscopy. Our results indicated that the layer thickness of fetal portion and surface area of lacuna of the fetal and maternal portion of placenta reduced in experimental group. In addition, maternal portion layer thickness and cell number of the fetal and maternal portion of placenta increased in the experimental group. Our results showed that oral morphine consumption could inhibit natural function of placenta lacuna and fetal cell development
Assuntos
Feminino , Animais de Laboratório , Desenvolvimento Embrionário/efeitos dos fármacos , Placenta/anormalidades , Placenta/efeitos dos fármacos , Placenta/crescimento & desenvolvimento , Ratos Wistar , Teratogênicos , Anormalidades Induzidas por MedicamentosRESUMO
The possible protective role of pomegranate (Punica granatum L.) fruit extract which has shown antioxidant capacity higher than that of red wine and green tea was evaluated against adriamycin-induced oxidative stress in chick embryos. Adriamycin (ADR), an anthracycline broad spectrum of chemotherapeutic drug is used for the treatment of variety of cancers; however, its prolonged use is limited by an irreversible, dose-dependant and progressive cardiomyopathy, hepatotoxicity and general toxicity to other organs in human beings, due to oxidative stress. The morphological changes (malformation of different organs), changes in body weight, volume of amniotic fluid (AF) and biochemical parameters of AF were studied after 24 and 48 h of incubation by comparing ADR alone and pomegranate fruit extract pretreated groups with their respective controls of 12 days old chick embryos. ADR alone at a dose of 70 microg/egg showed a significant dose versus time- dependent reduction in body weight, volume of AF. A dose-related increase in embryo gross morphological deformities and significant changes in the levels of biochemical parameters in AF were observed in ADR-treated group. These changes were significantly ameliorated to normal by pre-administration of pomegranate fruit extract at a dose of 200 microg/egg. Thus, the present study demonstrated the embryo protective nature of pomegranate fruit extract against ADR-induced oxidative stress.
Assuntos
Líquido Amniótico/efeitos dos fármacos , Animais , Antioxidantes/uso terapêutico , Peso Corporal/efeitos dos fármacos , Embrião de Galinha , Relação Dose-Resposta a Droga , Doxorrubicina , Desenvolvimento Embrionário/efeitos dos fármacos , Desenvolvimento Embrionário/fisiologia , Estresse Oxidativo/efeitos dos fármacos , Fitoterapia , Extratos Vegetais/uso terapêutico , LythraceaeRESUMO
A reliable and reproducible protocol has been developed for high frequency plant regeneration from 4-5 mm long leaf base segments of 4 days old in vitro germinated seedlings of indica rice (Oryza sativa) cultivar Rasi. The effect of age of seedlings, position of leaf base segments and optimum concentration of 2,4-D on callus induction frequency was investigated with a future aim to use leaf bases for biolistic and Agrobacterium-mediated transformation experiments. Friable, nodular and white to pale yellow embryogenic callus cultures (206 mg fresh weight /explant) were obtained from the first basal segments of rice seedlings on Linsmaier and Skoog (LS) medium supplemented with 2,4-D (11.3 microM) and 3.0 microM thiamine-HCL. Plant regeneration was achieved after the transfer of 54 days old embryogenic callus cultures to Murashige and Skoog (MS) medium supplemented with BAP (2.2 microM) and NAA (0.27 microM). In vitro regenerated plants with multiple shoots and roots transferred to sterile soil in growth chamber and maintained in greenhouse exhibited normal growth and were phenotypically similar to plants germinated from seeds.
Assuntos
Ácido 2,4-Diclorofenoxiacético/farmacologia , Meios de Cultura , Desenvolvimento Embrionário/efeitos dos fármacos , Oryza/efeitos dos fármacos , Oryza/fisiologia , Folhas de Planta/efeitos dos fármacos , Folhas de Planta/crescimento & desenvolvimento , Folhas de Planta/fisiologia , Regeneração/efeitos dos fármacos , Fatores de TempoRESUMO
The purpose of this study was to evaluate the effect of fibroblastic growth factor on resumption of meiosis, in vitro maturation of immature mouse oocytes and resulting embryo development with and without basic fibroblastic growth factor-4 [bFGF-4].Cumulus - oocyte complex [COCs] and germinal vesicle [GV] were obtained from female NMRI mice 46-48 hours after administration of an intra-peritoneal injection of 5 IU PMSG. COCs were cultured in TCM199 supplemented with different dosages of bFGF-4. After 24 hours, metaphase II [MII] oocytes were co-incubated with sperms for 4-6 hours in 16 medium. For all groups, the rate of cleaved embryos was assessed in the T6 medium until blastocyst stage. In all compared groups, the percentage of matured MII oocytes in the 10 ng/ml [%94.4] and 20 ng/ml [%92.5] of bFGF-4 treatment groups, was significantly higher [P<0.05] than those of the control group but the percentage of embryos that developed to blastocyst in 20 ng/ml bFGF-4 treatment group was significantly higher than those of the control group [P<0.05]. Exogenous bFGF-4 improved the oocyte maturation and embryo development
Assuntos
Feminino , Animais de Laboratório , Meiose/efeitos dos fármacos , Desenvolvimento Embrionário/efeitos dos fármacos , Fator 4 de Crescimento de Fibroblastos/farmacologia , Camundongos , Oócitos/efeitos dos fármacosRESUMO
OBJETIVO: avaliar a toxicidade do tacrolimus sobre o desenvolvimento embrionário em ratas tratadas durante o período de trânsito tubário. MÉTODOS: sessenta ratas Wistar foram distribuídas em quatro grupos (15 animais cada), que receberam diferentes doses de tacrolimus por via intragástrica: (T1) 1,0 mg/kg/dia, (T2) 2,0 mg/kg/dia e (T3) 4,0 mg/kg/dia. O grupo controle (C) recebeu água destilada. As ratas foram observadas diariamente para detectar sinais clínicos de toxicidade. O tratamento foi realizado do primeiro ao quinto dia de gestação. As seguintes variáveis maternas foram analisadas: peso corporal, de ovários, fígados e rins, consumo de alimento, número de corpos lúteos, implantes, fetos vivos e mortos e índice de implantação. Os fetos e placentas foram pesados e os primeiros foram observados para detectar malformações externas. Estatística: análise de variância (ANOVA), uma via, seguida de teste de Dunnett (alfa=0,05). RESULTADOS: não ocorreram indícios clínicos de toxicidade materna, tais como perda de peso, redução do consumo de alimento ou do peso de órgãos (p>0,05). Também não houve diferença significativa no peso corporal dos fetos (C: 1,8±0,6; T1: 2,2±0,5; T2: 1,9±0,5 e T3: 2,0±0,5 g) e de placentas (C: 1,6±0,4; T1: 1,5±0,4; T2: 1,8±0,4 e T3: 1,6±0,4 g), com p>0,05. Nenhuma malformação externa foi detectada. CONCLUSÕES: a administração de tacrolimus a ratas prenhes durante o período de trânsito tubário não parece ter qualquer efeito tóxico e materno ou embrionário.
PURPOSE: to evaluate the toxicity of tacrolimus on embryonic development in rats treated during the tubal transit period. METHODS: sixty Wistar rats were distributed into four groups (15 animals each), which received different doses of tacrolimus through intragastric administration: (T1) 1.0 mg/kg/day, (T2) 2.0 mg/kg/day and (T3) 4.0 mg/kg/day. The control group (C) received distilled water. The rats were observed daily to detect clinical signs of toxicity. The treatments were performed from the first to the fifth day of pregnancy. The following maternal variables were analyzed: body, ovary, liver, and kidney weights, food intake, number of corpora lutea, implants, alive and dead fetuses, and implantation rates. The fetuses and placentae were weighed and the former were observed in order to detect external malformation. Statistical analysis was performed by one way: analysis of variance (ANOVA), folowed by the Dunnet test (alpha=0.05). RESULTS: there were no signs of maternal toxicity, such as body weight loss, decrease in food intake or in organ weights (p>0.05). There was also no significant difference among weights of fetuses (C: 1.8±0.6; T1: 2.2±0.5; T2: 1.9±0.5 and T3: 2.0±0.5 g) and placentae (C: 1,6±0.4; T1: 1.5±0.4; T2: 1.8±0.4 e T3: 1.6±0.4 g), with p>0.05; no external malformation was detected in the fetuses. CONCLUSIONS: the administration of tacrolimus to pregnant rats during the tubal transit period does not seem to generate any toxic effect to mother or embryo.
Assuntos
Animais , Feminino , Gravidez , Ratos , Desenvolvimento Embrionário/efeitos dos fármacos , Imunossupressores/toxicidade , Tacrolimo/toxicidade , Ratos WistarRESUMO
PURPOSE: Exposure of male reproductive organs to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) has been reported to cause developmental changes. In this study, we evaluated the effects of in utero TCDD exposure on male reproductive development. MATERIALS AND METHODS: Pregnant C57BL/6 mice were administered a single intraperitoneal injection of TCDD (1microgram/kg) on gestation day (GD) 15. The offspring were examined in the immature stage on postnatal day (PND) 30 and in the mature stage on PND 60. The testes were examined for histological changes, androgen receptor (AR), proliferating cell nuclear antigen (PCNA) and apoptosis following the measurement of morphological changes. RESULTS: Anogenital distance (AGD) and testis weights were reduced by TCDD exposure both on PND 30 and PND 60 while body weights and length of male offspring were not affected by TCDD. The regular sperm developmental stage was impaired with TCDD treatment on PND 30. However, no difference was found between the control group and TCDD groups on PND 60. Simultaneously, the expression of AR was also reduced on PND 30, while it was increased on PND 60 compared with the control group. The expression of PCNA was decreased whereas apoptosis was not affected by TCDD both on PND 30 and PND 60. CONCLUSION: These results suggest that in utero exposure to TCDD influences the development of testes by inhibiting the expression of AR and PCNA. Moreover, the adverse effects of TCDD on male offspring reduced over time.
Assuntos
Animais , Feminino , Masculino , Camundongos , Gravidez , Apoptose/efeitos dos fármacos , Proliferação de Células , Desenvolvimento Embrionário/efeitos dos fármacos , Poluentes Ambientais/toxicidade , Exposição Materna , Camundongos Endogâmicos C57BL , Tamanho do Órgão/efeitos dos fármacos , Receptores Androgênicos/metabolismo , Testículo/efeitos dos fármacos , Dibenzodioxinas Policloradas/toxicidadeRESUMO
The aim of this study was to investigate whether demecolicne treatment of matured bovine oocytes adversely affects the process of in vitro fertilization and embryo development. Bovine Cumulus Oocyte Complexes [COC's] were matured in vitro and then were randomly allocated to two treatment groups of common concentrations of demecolicne [0.05 and 0.4 micro g/ml for 30 min] and a control group. COC's were then fertilized and cultured in vitro for up to 9 days when the ratios of in vitro embryo development and the viability of the hatched blastocysts were assessed and compared with the control group [p<0.05]. The ratios of the cleavage and blastocyst formation of demecolicne treated groups [0.4 and 0.05 micro g/ml] were 68.6, 63.5% and 23.3, 32.8%, which were not significantly different from the control group [73.3, 29.0%], respectively. The results of cell-viability were also not significantly different between the control vs. treatment groups. Since the overall indices of in vitro embryo development revealed no significant difference between the demecolicne treated compared to control bovine oocytes, it seems that demecolicne treatment of matured bovine oocytes may not compromise their potency for further in vitro development